
FedEx revitalizes partnership with Amazon, reshaping e-commerce logistics amid FedEx's efficiency drive and UPS's strategic pullback, highlighting shifting industry dynamics and competitive tensions.
JPMorgan highlights India's strong IPO market and economic resilience amid tariff and visa challenges, predicting continued growth despite international obstacles.
Saudi Arabia attracts global investment with Stride Ventures committing $200M, a local Airbnb rival planning an IPO, and stock market reforms boosting foreign ownership.
UK Big Pharma pulls investments, challenging the NHS's drug pricing controls, raising concerns over the UK's competitiveness in life sciences and potential impacts on public health policy.
The Trump administration faces backlash for suggesting Tylenol use during pregnancy links to autism, sparking concerns from UK health officials and healthcare professionals worldwide.
Rising oil prices hit global markets due to increased Russian crude exports, refinery strikes, and potential diesel curbs, creating a volatile energy landscape.
Bristol Myers Squibb's new schizophrenia drug, Cobenfy, priced at $22,500 annually, raises debate on UK drug pricing and regulatory approval challenges amid government cost-cutting pressures.
Trump's $100,000 H-1B visa fee overhaul strains India's outsourcing sector, risking $400 million in remittances and complicating India-US trade relations amid economic impacts.
Prince Alwaleed boosts investment in Snap amid its sales challenges, while Apple's stock nears record highs due to strong product demand and reduced tariff fears.
Monte Paschi acquires an 86.3% stake in Mediobanca, reshaping Italy's banking landscape, while UniCredit reduces its holding in Generali to 2%, reflecting strategic market shifts.
Pfizer acquires Metsera for $4.9 billion to bolster its obesity drug lineup, amid declining revenues from mature Covid-19 vaccines and intense pharmaceutical competition.
President Trump to meet Arab leaders at the UN amid heightened Gaza conflict tensions, as Israel's escalating military costs reach $7.5 billion, impacting regional diplomacy.